Low-grade Gliomas
What are Low-grade Gliomas?
Low-grade gliomas (LGGs) are slow-growing primary brain tumours that arise from glial cells, which provide structural and functional support to the nervous system. These tumours are typically classified as World Health Organisation (WHO) Grade 2 and are more commonly diagnosed in younger adults compared to high-grade malignant brain tumours. Although low-grade gliomas tend to grow more slowly, they can still significantly impact neurological function and may progress to more aggressive forms over time.
Types of Low-grade Gliomas
The 2 main subtypes of Low Grade Glioma are:
- Astrocytomas
- Oligodendrogliomas
Symptoms of Low-grade Gliomas
The common symptoms of low-grade gliomas vary depending on tumour size, growth rate, and location within the brain.
Neurological Symptoms:
- Persistent headaches
- Seizures (often the first presenting symptom)
- Cognitive or behavioural changes
- Memory difficulties
- Speech disturbances
- Motor weakness or coordination problems
- Visual disturbances
General Symptoms:
- Nausea or vomiting
- Fatigue
- Increased intracranial pressure in advanced cases
Risk Factors of Low-grade Gliomas
Although exact causes are not always clear, contributing factors may include:
- Genetic predisposition
- Prior radiation exposure
- Certain hereditary syndromes
- Family history of brain tumours
Diagnosis of Low-grade Gliomas
Diagnosis of low-grade gliomas involves detailed neurological and radiological assessment including:
- MRI brain with contrast (gold standard)
- Biopsy for histopathological confirmation
- Molecular testing (e.g., IDH mutation, 1p/19q codeletion)
Treatment of Low-grade Gliomas
Management of low-grade gliomas depends on tumour type, size, location, and the patient’s health status.
- Surgical resection: Preferred initial treatment when feasible
- Active surveillance: In select cases of slow-growing, asymptomatic tumour
- Targeted therapy: Vorasidenib (IDH inhibitor)
- Radiation therapy: For residual or progressive disease
- Chemotherapy: Commonly temozolomide or PCV regimen is recommended
Prognosis of Low-grade Gliomas
Low-grade gliomas generally have a better prognosis than high-grade gliomas, but outcomes vary based on molecular profile, age, and extent of the tumour and surgical removal. Long-term follow-up is essential, as recurrence or malignant transformation can occur.






